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Abstract Hyperemesis gravidarum (HG) is a pregnancy con-
dition characterised by debilitating nausea and vomiting. HG
has been associated with depression during pregnancy but the
direction of the association remains unclear. The aim of this
study was to assess whether previous depression is associated
with HG. This is a population-based pregnancy cohort study
using data from The Norwegian Mother and Child Cohort
Study. The study reviewed 731 pregnancies with HG and
81,055 pregnancies without. Logistic regression analyses
were performed to examine the association between a lifetime
history of depression and hyperemesis gravidarum. Odds ra-
tios were adjusted for symptoms of current depression, mater-
nal age, parity, body mass index, smoking, sex of the child,
education and pelvic girdle pain. A lifetime history of depres-
sion was associated with higher odds for hyperemesis
gravidarum (aOR = 1.49, 95% CI (1.23; 1.79)). Two thirds
of women with hyperemesis gravidarum had neither a history
of depression nor symptoms of current depression, and 1.2%
of women with a history of depression developed HG. A life-
time history of depression increased the risk of HG. However,
given the fact that only 1.2% of women with a history of
depression developed HG and that the majority of women
with HG had no symptoms of depression, depression does
not seem to be a main driver in the aetiology of HG.
Keywords Depression . Hyperemesis gravidarum .Mental
health . Nausea and vomiting . NorwegianMother and Child
Cohort Study
Introduction
Nausea and vomiting in pregnancy (NVP) is common and
affects up to 80% of all pregnancies (Gadsby et al. 1993).
Unlike NVP, hyperemesis gravidarum (HG) is characterised
by severe, debilitating symptoms. The International
Classification of Diseases (ICD-10) describes HG as exces-
sive vomiting starting before the 22nd week of gestation with
(severe HG) or without (mild HG) metabolic disturbances
(World Health Organization 2004). Although estimated to af-
fect 0.3 to 2% of all pregnancies (Eliakim et al. 2000), HG is a
primary reason for sick leave (Dorheim et al. 2013) and
hospitalisation during pregnancy (Gazmararian et al. 2002).
The aetiology and the pathogenesis of HG are unclear, and it
remains unknown whether NVP and HG are independent con-
ditions or if HG represents the extreme of a continuum of
NVP.
HG has historically been explained by a variety of psycho-
logical mechanisms that have been subjected to stigma
(Fairweather 1968). Other hypotheses have been proposed,
including genetic components (Corey et al. 1992; Fejzo
et al. 2008), endocrine factors and Helicobacter pylori infec-
tion, but none of these have proven sufficient to explain HG
(Verberg et al. 2005). Although, HG is today considered a
disease of unclear pathophysiology (Grooten et al. 2015),
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clinical practice still includes evaluation of hyperemetic wom-
en for psychiatric disease (Kim et al. 2009). Women with HG
report lack of support from their healthcare providers
(Heitmann et al. 2016; Poursharif et al. 2008), which may
have severe consequences such as termination of pregnancy
and psychological sequelae (Poursharif et al. 2008; Poursharif
et al. 2007).
HG has consistently been associated with mental distress
such as depression and anxiety. Previous studies are, however,
often small with a medium to high risk of bias (Mitchell-Jones
et al. 2016) or have limited availability of co-variates (Fell
et al. 2006; Seng et al. 2007). Prior research has mainly fo-
cused on the association between anxiety/depression and HG
during pregnancy, whereas the effect of anxiety/depression
prior to pregnancy remains to be elucidated. Furthermore,
few studies have used reliable psychometric instruments to
assess anxiety/depression before pregnancy, rendering causal
inferences difficult (Fell et al. 2006; Seng et al. 2007). Thus, a
key question remains of whether mental distress leads to HG
or HG leads to mental distress.
The aim of the present study was to assess whether a life-
time history of depression is associated with HG. The
Norwegian Mother and Child Cohort Study, comprising more
than 100,000 pregnancies, provides a unique opportunity to
explore this association.
Materials and methods
Study design and study population
From 1998 to 2008, all pregnant women scheduled to give
birth at 50 of Norway’s 52 hospitals with maternity units re-
ceived a postal invitation to participate in The Norwegian
Mother and Child Cohort Study (MoBa) together with ap-
pointments for routine ultrasound examination at aroundweek
17 of pregnancy. All participants signed an informed consent
form (Magnus et al. 2016; Magnus et al. 2006). MoBa was
approved by the Regional Committee for Medical Research
Ethics and by the Norwegian Data Protection Authority. The
protocol for the current study was submitted to the Norwegian
Institute of Public Health, who, upon approval, supplied the
researchers of this study with anonymised data through con-
tract (PDB 1527, www.fhi.no/moba).
The current study is based on version 8 of the quality-assured
data files linked to the Medical Birth Registry of Norway
(MBRN). The MBRN is based on the compulsory notification
of every birth or late abortion in Norway from the 16th week of
gestation, including information regarding pregnancy-related
complications (Irgens 2000). Approximately 40% of the invited
women participated, and each pregnancy was registered with a
unique identification number (Magnus et al. 2006).
The analyses of the current study are based on two ques-
tionnaires distributed in pregnancy week 17 (Q1) and week 30
(Q2). Q1 covers background factors including previous preg-
nancies, medical history before and during pregnancy, medi-
cation; occupation, lifestyle habits and mental health. Q2 pro-
vides information about the mental and physical health at this
stage of pregnancy as well as changes in work situation and
habits. English translations of the questionnaires can be found
at http://www.fhi.no/moba.
We included all singleton pregnancies (n = 112,288). We
excluded women with missing information on history of de-
pression (n = 3605), symptoms of depression at the 17th ges-
tational week, hospitalisation (n = 19,275), sex of the child
(n = 207) and education (n = 15,707). Some women had
missing values on more than one variable. The final sample
comprised 81.786, 72.8% of the total sample.
Variables
In accordance with previous studies on MoBa data (Vikanes
et al. 2010, 2013), HG was defined as prolonged nausea and
vomiting leading to hospitalisation before the 25th gestational
week as reported in Q2 (week 30). This definition was chosen
in order to clearly separate HG from normal levels of NVP.
The main predictor was a lifetime history of depression,
measured by the Kendler’s lifetime major depression scale
(KLTDS). The KLTDS was defined using five of the nine
symptomatic criteria for major depression in DSM-III-R:
Have you ever experienced the following for a continuous
period of 2 weeks or more: (1) felt depressed, sad; (2) had
problems with appetite or eaten too much; (3) been bothered
by feeling weaker or a lack of energy; (4) really blamed your-
self and felt worthless and (5) had problems with concentra-
tion or had problems making decisions. The response to each
question was yes or no. A history of depression was defined as
present if a minimum of three of the five symptoms and sad
mood were reported to occur simultaneously for more than
2 weeks (Kendler et al. 1993).
A five-item short version (SCL-5) of the Hopkins
Symptom Checklist-25 (SCL-25) was used as a proxy for
current depression in pregnancy week 17. The SCL-5 is high-
ly correlated with the SCL-25 (correlation coefficient of 0.92)
(Tambs and Moum 1993) and consists of the following ques-
tions: Have you been bothered by any of the following during
the last 2 weeks: (1) feeling fearful, (2) nervousness or shak-
iness inside, (3) feeling hopeless about the future, (4) feeling
blue and (5) worrying too much about things. The response
categories ranged from ‘not bothered’ to ‘very bothered’
(range 1–4), with a maximum total score of 20. Symptoms
of current depression were defined as a mean score >2
(Strand et al. 2003), which has been shown to provide the
same prevalence estimate of a depressive disorder as the
Composite International Diagnostic Interview (Robins et al.
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1988; Sandanger et al. 1998). Missing values in the
dichotomised version of the SCL-5 were handled as follows.
First, the average score on existing items was calculated for
each case if at least three of five questions were answered. If
the average of the existing items was clearly above or below
the cut-off and could not be affected by imputation of missing
values, it was dichotomised to zero or one, as appropriate.
Imputation was not performed in cases where the average
score was not uniquely defining the value above or below
cut-off. Altogether, N = 18 cases were imputed.
Co-variates and possible confounders obtained from the
MBRN included sex of the child (Rashid et al. 2012), maternal
age and parity. Co-variates and possible confounders obtained
from MoBa Q1 were socio-economic status, BMI and
smoking (Vikanes et al. 2010). Pelvic girdle pain was obtained
from MoBa Q2 (Bjelland et al. 2013; Chortatos et al. 2015).
Regarding parity, women were dichotomised as either primip-
arous or multiparous. Education was used as a proxy for
socio-economic status, and length of education (in years)
was divided into three categories. Pre-pregnancy body mass
index (BMI) was calculated as weight/height2. Women shorter
than 120 cm (n = 199) and women weighing more than 150 kg
or less than 40 kg were excluded (n = 58). Also, those
reporting reduction in weight by more than 20 kg or increase
in weight bymore than 50 kg since the start of pregnancy were
excluded (n = 65). Smoking was assessed as a yes/no response
to the question ‘did you smoke 3 months before pregnancy’
(Vikanes et al. 2010). Pelvic girdle pain was defined as pain in
the anterior pelvis and on both sides in the posterior pelvis
(Bjelland et al. 2013).
Other co-variates including H. pylori infection (Li et al.
2015), gastrointestinal disorders, rheumatoid arthritis, pre-
eclampsia, chronic hypertension, type 1 diabetes, asthma
(Bolin et al. 2013; Fell et al. 2006; Jorgensen et al. 2012),
eating disorders (Torgersen et al. 2008) and ethnicity
(Vikanes et al. 2008) were considered but not included in the
final analysis due to a small number of women with these
disorders in the HG group. Thyroid disease was not included
in the analysis as the questionnaire form does not allow dif-
ferentiation between hypothyroid and hyperthyroid disease.
Statistical analysis
Demographic and clinical characteristics among women with
and without HG and for the entire sample were presented as
frequencies and percentages or means and standard deviations
(SD).
To assess the association between a lifetime history of de-
pression and HG, a logistic regression model was estimated.
Due to multiple births, some women had several recordings in
the data set. According to the intra-women correlation coeffi-
cient, there was some degree of clustering detected. Thus, the
generalised estimating equations (GEE) model correctly
adjusting the estimates for intra-women correlations was
fitted.
A number of potential predictors and confounders were
considered. In order to test our hypotheses, a data splitting
approach was applied (Dahl et al. 2008). According to this
approach, the data set was split into two random parts contain-
ing approximately 30% (part I) and 70% (part II) of observa-
tions. Splitting was performed within stratas defined by sev-
eral key variables. Part I (pilot) was used to construct a model
for HG. Only predictors significant at the 5% level or those
otherwise considered important were left in the model estimat-
ed on pilot data. The hypothesis testing was then performed on
part II (test) data. Only the results with P values below 0.05 in
the test data analyses were accepted as significant, regardless
of significance level in the pilot part. Once the hypotheses
were tested, the model was estimated on the entire data set
to achieve most accurate estimates for the model parameters.
Due to the numerous predictors considered, the level of sig-
nificance was set to 0.005 when interpreting the results in the
entire data set.
The interaction between BMI and smoking status was
assessed and kept in the model if significant.
All analyses were performed by SPSS v 22.
Results
Characteristics for the HG group and comparison group are
presented in Table 1. The mean age of pregnant women was
30.3 years (15–47 years; SD 4.5 years) and 45% were primip-
ara. A total of 731 (0.9%) women reported hospital admission
due to HG. More than 20% (17,351/81,786) of the women
reported a lifetime history of depression, whereas 6.1%
(4981/81,786) reported symptoms of current depression at
the 17th gestational week.
In the binary logistic regression model, a lifetime history of
depression was associated with higher odds for HG (unadjust-
ed OR = 1.53, 95% CI (1.29; 1.83)). Adjusting for potential
confounders including symptoms of depression in gestational
week 17 did not influence our results (adjusted OR = 1.49,
95% CI (1.23; 1.79)).
Symptoms of depression at the 17th gestational week was
independently associated with HG in the multivariate model
(OR = 1.71, 95% CI (1.31; 2.23)). As shown on Table 2, other
factors positively associated with HG included short educa-
tion, female sex of the child, multiparity, younger age of the
mother and pelvic girdle pain. Pre-pregnancy BMI did not
differ between women with and without HG, and smoking
was negatively associated with HG.
We also assessed whether women with a history of depres-
sion were more likely to be hospitalised during pregnancy in
general. Among women with previous depression, 7.7% were
hospitalised during pregnancy compared to 5.2% without;
History of depression and risk of hyperemesis gravidarum
history of depression was associated with higher odds for
hospitalisation (OR = 1.52, 95% CI (1.42; 1.62)).
Although HG was positively associated with depression,
the majority of women with HG (66%, 489/740) neither had
a lifetime history of depression nor symptoms of depression in
the 17th gestational week as shown in Fig. 1. Furthermore,
only 1.2% of womenwith previous depression developed HG.
Discussion
The main finding of the present study was that having a life-
time history of depression was associated with 50% higher
odds for HG. The majority of women with HG did not, how-
ever, have a history of depression, and less than 2% of women
with previous depression developed HG.
The results are in line with previous research. Using health
insurance data from the Midwestern USA between 2000 and
2004, Seng et al. (2007) found that a diagnosis of depression
before pregnancy was positively associated with HG in a pop-
ulation of 11,016 women, including 208 HG pregnancies
(OR = 3.2, 95% CI (2.0; 5.2)). Additionally, they found that
the burden of illness increased the likelihood of HG. Having
had a psychiatric or somatic condition before pregnancy in-
creased the odds for HG twofold, while having had both a
psychiatric and somatic condition increased the odds fourfold.
The study design permitted the identification of psychiatric
diagnoses occurring before pregnancy, but information about
other co-variates was limited.
Another large cohort study comprising 157,922 women, of
whom 1301 had HG, was extracted from a population-based
healthcare database covering all deliveries to residents of Nova
Scotia, Canada, between 1988 and 2002 (Fell et al. 2006). The
Table 1 Characteristics of the sample according to HG status among
81,786 women
HG n (%) No HG n (%) Total n (%)
History of depression
No 520 (71.1) 63,915 (78.9) 64,435 (78.8)
Yes 211 (28.9) 17,140 (21.1) 17,351 (21.2)
Symptoms of current depression
Low score 650 (88.9) 76,155 (94.0) 76,805 (93.9)
High score 81 (11.1) 4900 (6.0) 4981 (6.1)
Parity
Primipara 287 (39.3) 36,480 (45.0) 36,767 (45.0)
Multipara 444 (60.7) 44,575 (55.0) 45,019 (55.0)
Length of education (years)
<12 79 (10.8) 5599 (6.9) 5678 (6.9)
13–16 536 (73.3) 56,034 (69.1) 56,570 (69.2)
>16 116 (15.9) 19,422 (24.0) 19,538 (23.9)
Smoking
No 495 (79.5) 49,153 (69.3) 49,648 (69.4)
Yes 128 (20.5) 21,811 (30.7) 21,939 (30.6)
Sex of the child
Boy 307 (42.0) 41,571 (51.3) 41,878 (51.2)
Girl 424 (58.0) 39,484 (48.7) 39,908 (48.8)
Pelvic girdle pain
No 583 (79.8) 69,145 (85.3) 69,728 (85.3)
Yes 148 (20.2) 11,910(14.7) 12,058 (14.7)
HG mean (SD) No HG mean (SD) Total mean (SD)
Maternal age 29.3 (4.9) 30.3 (4.5) 30.3 (4.5)
Pre-pregnancy BMI 24.5 (4.2) 24.1 (4.3) 24.1 (4.3)
Table 2 Unadjusted and adjusted
odds ratios (OR) with 95% confi-
dence intervals (CI) for
hyperemesis gravidarum








No 1 – 1 –
Yes 1.53 (1.29; 1.83) < 0.001 1.49 (1.23; 1.79) <0.001
Symptoms of current depression
Low score 1 – 1 –
High score 2.11 (1.65; 2.69) < 0.001 1.71 (1.31; 2.23) <0.001
Maternal age 0.94 (0.93; 0.96) < 0.001 0.93 (0.91; 0.95) <0.001
Parity
Primipara 1 – 1 –
Multipara 1.24 (1.05; 1.45) 0.010 1.43 (1.20; 1.69) <0.001
Length of education (years)
<12 2.42 (1.76; 3.32) < 0.001 1.91 (1.36; 2.69) <0.001
13–16 1.64 (1.31; 2.06) < 0.001 1.44 (1.13; 1.82) 0.003
>16 1 – 1 –
Pre-pregnancy BMI 1.03 (1.01; 1.04) 0.002 1.02 (1.00; 1.04) 0.030
Smoking
No 1 – 1 –
Yes 0.60 (0.49; 0.72) <0.001 0.46 (0.37; 0.56) <0.001
Sex of the child
Boy 1 – 1 –
Girl 1.49 (1.27; 1.75) <0.001 1.50 (1.28; 1.76) <0.001
Pelvic girdle pain
No 1 – 1 –
Yes 1.52 (1.25; 1.85) <0.001 1.30 (1.06; 1.59) 0.011
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study revealed a fourfold higher risk of HG in women with
psychiatric disease (RR = 4.1, 95% CI (3.0; 5.7)). The timing
or types of psychiatric disease were not specified, but a crude
RR of 2.5with 95%CI (1.5; 4.2) was reported for HG inwomen
with depression compared to women without depression.
On the other hand, Magtira et al. (2014) found no statisti-
cally significant differences in the prevalence of psychiatric
conditions prior to the first pregnancy when comparing 84
women with recurrence of HG with 34 women with no recur-
rence. The authors predicted that if psychiatric symptoms pos-
itively correlate with HG, then psychiatric symptoms would
correlate positively with recurrence risk. As the study was
based on data from an online survey, the participating women
were not randomly selected among women with HG and may
therefore have had a different risk profile from the women
who did not participate (Bornehag et al. 2012). Additionally,
only women who had had at least two pregnancies lasting
beyond the second trimester were included, which may intro-
duce recall bias, e.g. whether psychiatric symptoms preceded
pregnancy, or selection bias as women with poor psychosocial
health may have been less likely to continue participation, as
were women terminating their pregnancies due to HG
(McDonald et al. 2013).
Given the nature of theMoBa data, we were able to explore
whether symptoms of depression in the current pregnancy
were independently associated with HG. Consistent with a
recent meta-analysis (Mitchell-Jones et al. 2016), we found
an association between HG and depression during pregnancy.
Two prospective studies, both excluding women with a histo-
ry of psychiatric disease, also reported that women with HG
were more likely to suffer from symptoms of anxiety and
depression during pregnancy compared to asymptomatic
pregnant women (Aksoy et al. 2015; Pirimoglu et al. 2010).
It was therefore argued that psychological distress was a con-
sequence of HG rather than the cause (Aksoy et al. 2015).
Since hospitalisation due to prolonged NVP was a require-
ment for having HG in the current study, our results may have
been biased by a greater likelihood of being hospitalised
among women with a history of depression (Atanackovic
et al. 2001). A relationship between depression and severity
of NVP has previously been suggested (Kelly et al. 2001;
Mazzotta et al. 2000) although other studies do not support
this finding (Swallow et al. 2004; Tan et al. 2010). We there-
fore assessed whether women with previous depression were
more likely to be hospitalised in general during pregnancy.
Previous depression was associated with hospitalisation
(OR = 1.52, 95% CI (1.42; 1.62)), which may have contrib-
uted to overestimating the effect of previous depression on the
risk of HG. However, in Norway, only women with severe
symptoms of HG, including metabolic disturbances, are
hospitalised. Additionally, there is no tradition for outpatient
treatment for these patients. This indicates that our sample is
restricted to severe HG cases corresponding to ICD 10 code
O21.1, and it is therefore unlikely that the women have been
hospitalised due to depression. Given that hospital care in
Norway is free of charge, it is furthermore unlikely that more
socially disadvantaged women are less likely to be
hospitalised.
Several studies show that a variety of somatic diseases such
as pelvic girdle pain, H. pylori infection, thyroid disease, gas-
trointestinal disorders, rheumatoid arthritis, pre-eclampsia,
chronic hypertension, type 1 diabetes, asthma and eating disor-
ders are associated with higher risk of HG (Bolin et al. 2013;
Fell et al. 2006; Jorgensen et al. 2012; Li et al. 2015; Seng et al.
2007; Torgersen et al. 2008). However, in the present study, the
number of HG cases with these conditions was too small to
Fig. 1 The total number of
women with a HG (n = 731), b a
history of depression (n = 17,351)
and c symptoms of current
depression (n = 4981) among
81,786 women in the Norwegian
Mother and Child Cohort Study.
The number of women with HG
and a history of depression (ab,
n = 211); with HG and symptoms
of current depression (ac, n = 81)
and with HG, a history of
depression and symptoms of
current depression (abc, n = 50).
The number of women with no
HG and a history of depression
and symptoms of current
depression (bc, n = 2910)
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explore possible influences of these conditions. Our results
should be interpreted with these limitations in mind.
HG is a diagnosis by exclusion and an international con-
sensus on the definition of HG is yet to be established, limiting
comparison of previous research (Mitchell-Jones et al. 2016).
The lack of consensus is a challenge for clinicians who may
need to distinguish milder forms of HG from more common
nausea and vomiting in pregnancy (Grooten et al. 2015).
Inadequate care of women with HG may have severe conse-
quences including therapeutic abortions, Wernicke’s enceph-
alopathy and even death (Eliakim et al. 2000; Poursharif et al.
2007). Adverse pregnancy outcomes such as low birth weight
and preterm delivery may in particular affect HG women with
poor pregnancy weight gain (<7 kg) (Dodds et al. 2006).
Adequate care of women with HG is thus of the utmost
importance.
To our knowledge, this is the first time a large, high-quality
data set enables the study of the associations between a history
of depression and HG and symptoms of depression during
pregnancy and HG. Our results advocate that routine psychi-
atric consultations of HG women may be unnecessary.
Treatment should focus on relief of somatic complaints and
ensure the health of the mother and child.
The large number of HG pregnancies is a major
strength of the current study. Furthermore, the study cov-
ered all regions of Norway, and the prospective nature of
data collection minimises the risk of recall bias. To date,
more than 400 articles have been published based on
MoBa data. Around 40% of the invited women participat-
ed in the study, introducing a possibility of self-selection
bias. However, a recent study looking into potential bias
by skewed selection of participants in MoBa found that
the participant selection influenced the prevalence esti-
mates but not the exposure outcome associations (Nilsen
et al. 2009). Women known to be underrepresented in MoBa
include single women, those with shorter education, those
under 25 years of age, immigrants and smokers (Nilsen et al.
2009; Vikanes et al. 2010). Hospitalisation for HG was
assessed retrospectively; however, recall bias is highly unlike-
ly due to the relatively short interval between hospitalisation
and reporting of HG in week 32 of pregnancy (Vikanes et al.
2010). The comparison group comprised all other pregnant
women in the study, including those with complications other
than HG, reducing the risk of overestimating the association
between previous depression and HG.
The KLTDS and SCL-5 are the only available mea-
sures of mental health in the MoBa study. Unlike clin-
ical interviews, the KLTDS and SCL-5 cannot be used
to diagnose depression. The scales have, however, been
developed and validated to measure symptoms of de-
pression in population studies. Extensive questionnaire
studies with a broad scope such as the MoBa study
often have a shortage of space for the original lengthy
psychometric instruments, and short versions may be
useful to improve response rates. While the short ver-
sions affect the measurement precision, the precision
remains sufficient for epidemiological purposes (Strand
et al. 2003; Tambs and Moum 1993; Tambs and
Røysamb 2014).
The fact that a history of depression was not measured
before pregnancy is a limitation of our study. Women
responded to the KLTDS in gestational week 17, which
for most women with HG is after the onset of severe
nausea and vomiting. This may have affected their re-
sponse. In our analyses, we therefore adjusted for symp-
toms of current depression at the 17th gestational week
to quantify the direct effect of a previous depression on
HG. The effect estimates changed only slightly in the
adjusted model indicating that KLTDS and SCL-5 cover
different aspects of women’s mental health in relation to
HG.
Conclusion
In conclusion, a lifetime history of depression increased the
odds for hospitalisation for HG by approximately 50%.
However, two thirds of women with HG had neither a history
of depression nor symptoms of depression at the 17th gesta-
tional week. Given the fact that only 1.2% of women with
previous depression developed HG, depression does not ap-
pear to be a main driver in the aetiology and pathogenesis of
HG. Our results advocate that routine psychiatric consulta-
tions may be unnecessary.
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